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ABSTRACT
Sickle Cell Disease (SCD) is an incurable, chronic condition that results in a constellation
of disorders, frequent emergency department (ED) visits, and repeated hospital
admissions. Those affected often suffer from pain crisis, infection, acute chest syndrome,
stroke, and multi-organ impairment and frequently do not receive adequate pain
management during acute pain episodes because ED providers view them as drug
seeking. The majority of patients with SCD are African-American and may be low
income, uninsured, or on Medicaid. As a result, these demographics make ED undertreatment of pain in patients with SCD a health equity issue. This was a pre-experimental
one group pre-test/post-test quality improvement project to evaluate the effectiveness of
implementation of an evidence-based analgesic algorithm coupled with an intervention
on practice change behavior towards patients with SCD. The intervention was an
educational video and introduction of an evidence-based analgesic prescribing algorithm
(ED-SCANS Decision 2). The outcome variables were provider perceptions (assessed by
the Positive Provider Attitudes towards Sickle Cell Patients questionnaire) and levels of
pain in SCD patients before and after the intervention. The results of this project
indicated that there was a significant improvement in provider attitudes between the pretest and post-test scores (p<.001). There was a significant difference (p<.002) between
discharge LOP, with the LOP approximately 3 points lower post-intervention; indicating
that the overall results of this QI study demonstrated positive outcomes (improved
provider perceptions and improvement in discharge LOP) from the applied intervention.
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CHAPTER 1
INTRODUCTION
Background and Significance
Sickle Cell Disease (SCD) is an incurable, long-term condition that results in
chronic manifestations of acute painful crises (vaso-occlusive crisis or VOC), frequent
emergency department (ED) visits, and repeat hospital admissions. Those affected often
suffer from pain crisis, infection, acute chest syndrome, stroke, and multi-organ
impairment and often do not receive adequate pain management during acute pain
episodes because ED providers view them as drug seeking. Because the majority of
patients with SCD are African-American and may be low income or uninsured or have
Medicaid, these demographics make ED under-treatment of pain in patients with SCD a
health equity issue.
Problem Statement
Baptist Health Medical Center Little Rock Emergency Department (BHMC-LR)
is one of the leading acute care facilities in Arkansas. From 2009-2011, the hospital
instituted certain quality improvement initiatives, including the development and
adaptation of treatment protocols for selected Diagnostic Related Groups (DRGs).
However, SCD is not included in these protocols due to at least two possible reasons: 1)
perceived physician resistance or reluctance to treat patients with SCD; or 2) a lack of
current knowledge and awareness of the benefits of using an established protocol to
identify and treat these patients upon their entrance into the ED setting.
Physicians play a vital role in coordinating care for SCD patients. Therefore, it is
crucial these providers have a comprehensive knowledge base and a perspicacious ability
1

to think critically when treating these patients in the ED. Complications that characterize
SCD disease presentations in the ED setting and recognition of the severity of VOC must
be at the forefront of ED physicians’ practices when providing care for SCD patients.
These complications include pain that physicians may perceive as drug-seeking behavior,
frequent visits to the ED, clinician and patient knowledge deficits, and SCD stigma
(Tanabe, 2011). Identifying appropriate treatment modalities for SCD patients who
present to the ED with VOC can decrease hospitalizations and re-admission rates,
inevitably decreasing costs for the hospital system because more than 1,000 patients who
suffer from SCD live in Arkansas. While the majority of these patients have taxpayerfunded insurance sources, the remainder has no insurance and place a major burden on
Arkansas’s health care system to provide unreimbursed care.
This Quality Improvement (QI) project had the potential to benefit the hospital
with respect to a reduction in readmission rates related to SCD. This is important for cost
containment, which is a major area of focus for hospitals. The Centers for Medicare and
Medicaid Services (CMS) released the Inpatient Prospective Payment System (IPPS) in
August 2011 as a structured framework to reduce hospital readmission rates through the
Hospital Readmission Reduction Program (HRRP), which is slated to begin in 2013
(Lenz & Hardcastle, 2011). This program creates a system of penalties for hospitals that
have high rates of readmission for specific diagnoses. The initial three diagnoses (heart
attack, heart failure, and pneumonia) will be used to compare 30-day readmission rates,
defined as “a patient being discharged to a non-acute setting and subsequently readmitted
or admitted to another acute care hospital within thirty days of discharge” (Lenz &
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Hardcastle, 2011, p.1) in 2012. By 2015, the diagnostic categories include chronic lung
conditions, vascular diseases, and other diagnoses not identified to date.
Scope of the Problem
The conditions of SCD and VOC result in frequent hospital encounters, especially
through the ED. There is evidence that ED providers and clinicians do not properly
identify, treat, or manage care for SCD patients most likely due to misperceptions
towards patients who suffer from this incurable disease (Ratanawongsa et al., 2009).
Improper treatment of patients suffering from SCD results in re-hospitalizations with
increased expenditures for the health care industry. This project assessed the
effectiveness of a video intervention and the institution of an analgesic treatment protocol
to promote change in the implementation of appropriate treatment for SCD patients
treated at BHMC-LR ED.
Tanabe et al. (2010) conducted one of the first prospective, multisite, longitudinal
cohort studies, using a learning collaborative model to evaluate analgesic management in
the ED setting. More than 75% of patients had one to three repeat visits over one year,
which will affect CMS reimbursement under the IPPS if SCD is added as a diagnosis, as
repeat admissions will result in unpaid hospital charges, with concomitant increases in
expenditures. Hospitals must implement standard and appropriate treatment of SCD
patients with VOC not only to improve patient care, but also to improve reimbursement.
Patients who suffer from SCD often present to the ED due to VOC pain, which
requires high dose opioids. If these patients are hesitant to seek treatment for their
conditions, their risk of health detriment is increased. Instead, these patients require
prompt assessment and intervention in order to interrupt this painful cycle. It is
3

imperative that providers respond appropriately to these patients, providing nonjudgmental analgesic treatment. If patients who suffer from SCD/VOC receive optimal
pain management and treatment in the ED, then these patients may be less likely to have
frequent repeat readmission rates. This will coincide with the HRRP by decreasing repeat
ED visits and hospitalizations for SCD.
Purpose
The objective of this project was to improve current analgesia practices for SCD
patients at (BHMC-LR ED. This QI project compared the pain control effectiveness of
current analgesia practices for SCD patients at BHMC-LR ED with the effectiveness after
implementation of an evidence-based analgesia support algorithm, coupled with an
educational video shown to improve care for these patients.
Goals and Objectives
The goal of this project was to improve provider perceptions and actions related
to care of patients with SCD. If provider perceptions are changed (Haywood et al., 2010),
then practice behaviors may change, resulting in improved clinician attitudes, behaviors,
and treatment for SCD patients who present to the ED. The providers will then use the
analgesic treatment protocol in standard practice when treating these patients. A key
strategy to reach this project goal was the implementation of an evidence-based analgesic
management algorithm, thereby improving providers’ attitudes and actions related to
providing care and treatment to SCD patients in the ED.
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This project’s process objectives included the following:
•

BHMC-LR ED physicians and nurses will be required to watch the intervention
video;

•

BHMC-LR ED physicians will be encouraged to use the ED-SCANS Decision
Algorithm to guide analgesic prescribing for SCD patient encounters; and

•

ED providers will change practice behaviors after the intervention when caring
for patients with SCD/VOC.
This project’s outcome objectives include the following:

•

Adoption of a decision support tool (i.e., ED-SCANS Decision 2) to help support
decision-making and treatment of SCD patients in the ED; and

•

Improved analgesic care for patients with SCD/VOC.

Policy Implications
Based on the findings of this project, recommendations were made to BHMC-LR
administration, the ED medical director, the ED supervisor, and the BHMC-LR
interdisciplinary team regarding the importance of prompt triage and medical assessment
of SCD patients who present to the ED. These patients require high dose analgesia,
hydration, and other hemodynamic assessment parameters in order to prevent mortality,
which can result from VOC. SCD is a global health problem and initiatives must be
developed in order to decrease morbidity and mortality associated with this genetically
linked, incurable disease. By providing prompt assessment and appropriate analgesia
during VOC, repeat hospitalizations.
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CHAPTER 2
THEORETICAL FRAMEWORK
Lewin’s Change Management Model
Because of shortcomings in identification, treatment, and management of patients
who suffer from SCD at BHMC-LR ED, the student implemented this QI project.
Lewin’s Change Management Model (LCMM) was selected as the theoretical
framework. In this model, Lewin identified three stages of change: unfreezing, changing,
and refreezing (as cited in Buonocore, 2004, p. 1).
The first stage involves the identification of the occurrences that prompt the need
for change. When all entities involved become a part of the identified need for change,
then unified participation is possible. A motivation to enact change in current practice
prompts the first stage (Buonocore, 2004). At BHMC-LR ED, the clinicians and social
workers stated they were motivated to help identify measures that would improve ED
treatment modalities for patients with SCD. Because of this motivation and a diagnosis of
the problem in practice, then planning solutions fostered a stimulus for change in
behavior (Buonocore, 2004).
The need for medical treatment for patients with SCD in Arkansas is increasing.
These patients have no cure for their condition and must endure the status quo until
treatments improve. Hospitals in Arkansas are working to stratify options for reducing
costs within their system, but this is hindered by repeat ED encounters by SCD in VOC.
The costs for treatment are often placed among charges that are considered
umreimbursable. This disrupts efforts to reduce cost escalation within the hospital
system. Providers are then burdened with repeat patient visits in the ED with the
6

assumption that these services will not be paid upon culmination of each repeat
encounter. The first stage (unfreezing) provides a theoretical basis on how to reduce
obstacles to change, which will likely interrupt the above described cycle, increasing the
potential for success of this QI project. Stakeholders are more apt to participate in the
proposed change if the benefits are described in the initial stages of the project.
The second stage, change, is the alteration of current practices (i.e., attitudes,
behaviors, inherent belief patterns in these providers, and improper analgesic
administration) to optimize improvement in patient outcomes in the BHMC-LR ED
(Buonocore, 2004). Theoretical knowledge channeled with experience in both
organizational (BHMC-LR) and patient needs enabled the adaption of Lewin’s model to
serve as a basis for “unfreezing” present behaviors and processes at BHMC-LR. This
enabled a change to occur (the second stage of Lewin’s model), thereby leading to a
“refreezing” (the third stage of Lewin’s model) of provider practice behavior and
evidence-based treatment in this QI project. Refreezing involves maintenance of the
implemented change. This QI project was designed to permanently improve provider
practice attitudes and treatment behaviors towards SCD patients in the BHMC-LR ED.
Participation in this project was designed to permit the ED providers to claim a
sense of ownership of the success of the project. Levasseur (2001) concluded that one
key element in the unfreezing stage (to prevent project failure) is the eliciting of effective
modes of communication at the stimulus phase in order to implement change so that all
stakeholders are active participants involved in empowering the organizational success of
the project’s anticipated goal.
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Patients and their families were also identified as stakeholders who will directly
benefit from this project. The physicians involved identified existing biases which
impede prompt diagnosis of patients who have SCD (with or without VOC) and foster
development of change in triage and management of these patients.
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CHAPTER 3
LITERATURE REVIEW
Sickle cell disease (SCD) is a complex, genetic (autosomal recessively inherited),
multi-system illness that affects 7% of the global population, including approximately
80,000 African-Americans (Taylor, Stotts, Humphreys, Treadwell, & Miaskowski, 2010).
Caused by a genetic mutation resulting in glutamic acid substitution for amino acid in the
sixth position of the mature Beta-globin chain, SCD results in polymerization and
deoxygenation of hemoglobin. This leads to the deformation and density of red blood
cells in patients with SCA (Brown, 2012; Mousa & Qari, 2010), causing chronic
manifestations of acute painful crises known as VOC (Brown, 2012). This long-term
condition results in frequent visits to the ED, with 90% of patients requiring inpatient
admission because of painful episodes of the sickle cell crisis (Brown, 2012). Due to the
pathophysiology (vaso-occlusion) of sickle cell anemia (SCA), these patients have
increased morbidity and mortality attributed to acute and chronic complications. These
include pain crisis, infection, acute chest syndrome, stroke, and multi-organ (brain, heart,
lungs, liver, bone, skin, kidneys) hemolysis (Mousa & Qari, 2010).
Patients who suffer from SCA and SCD present frequently to the ED because of
VOC, appearing very ill and presenting extreme subjective complaints of pain, often
requiring high doses of opioids. ED medical providers are faced with repeat patient
encounters, often related to uncontrolled pain. However, it may be difficult for providers
to distinguish objectively patients who have SCD with VOC-generated pain from
individuals who present with other subjective and undetermined causes of pain or who
are drug seeking because of addiction.
9

Approximately 980,000 individuals are addicted to opiates nationally (CNN
Health, 2010). CNN Health (2010) reports that between 2004 and 2009, there had been a
111% surge in ED visits entailing therapeutic misuse of prescription opiate analgesics,
with correlated data that validates prescription medication abuse as the most accelerating
drug problem in the country. These statistics are a compelling concern for ED physicians
and frequently create the potential to discount analgesia requests by patients in the ED.
However, patients who live with SCD must be managed on a long-term basis for
acute episodes of pain (Epstein, Yuen, Riggio, Ballas, & Moleski, 2006), as well as be
given general health maintenance and follow-up care. Therefore, these patients typically
interface with the health system for episodic pain not controlled via oral analgesia,
resulting in frequent utilization of the ED for treatment. 90% of all patients who present
to the ED in VOC are admitted for inpatient treatment (Epstein et al., 2006).
In addition, re-hospitalization is frequent among patients with SCD with one-infive patients having greater than three encounters annually (Brousseau, 2010) and one-inthree re-hospitalized within 30 days. This was greater in comparison to other diseases
(heart failure, diabetes mellitus, asthma, and pneumonia) frequently seen in the ED
(Brousseau, 2010), resulting in increased health expenditures. However, it is very likely
that if proper acute care management of SCD patients is instituted with outpatient followup visits (Brousseau, 2010), then re-encounters can be decreased.
The Sickle Cell Disease Association of America, Inc. (SCDAA) estimates that in
the United States more than 100,000 individuals have the disease. In addition, numerous
other organizations also address treatment issues surrounding SCD, including the
NAACP, Urban League, National Institutes of Health (NIH), Health Resources and
10

Services Administration, Centers for Disease Control and Prevention (CDC), United
Way, and the Robert Wood Johnson Foundation, by employing efforts at knowledge
advancement and treatment (Sickle Cell Disease Association of America, 2012).
President Richard Nixon signed into law the Sickle Cell Anemia Control Act in
1971, which contained provisions to decrease prior neglect of persons with SCD by
allotting monies for screening, education, and research towards SCD. Furthermore,
President George W. Bush signed the Sickle Cell Treatment Act in 2003, which contains
major initiatives to enhance care quality globally for patients suffering from SCD
(SCDAA, 2012). As a result, diagnosticians are in primary positions to engage in practice
change initiatives and service improvement for SCD patients.
However, improving access to proper treatment requires that clinicians be
knowledgeable and receptive to the needs of these patients. Perceptual biases may
pervade treatment modalities when these patients seek help during painful crises.
Therefore, this project focused on the education of ED providers by allowing them to
view SCD patients as individuals in need of help for an incurable disease that health care
providers often stigmatize.
Provider attitudes can have a negative impact on the general receptiveness to
providing optimal care to SCD patients. A study by Lattimer et al. (2010) found that SCD
patients often report problems with receiving treatment, especially pain relief from ED
providers. These patients also stated that they are undertreated and accused of behaviors
that mimic those of drug-seekers, with clinicians displaying negative and judgmental
attitudes towards their pain. Providers (physicians and nurses) often assume that SCD
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patients develop addictions to opioids, although current literature supports the claim that
there are only rare instances of addiction among these patients (Lattimer et al., 2010).
SCD patients who encounter negative experiences in the health care industry have
increased risk for morbidity associated with their disease, resulting from their hesitation
to seek care and treatment and from the resulting improper treatment for their disease.
For example, Lattimer et al. (2010) measured the hospital encounters of 45 patients via a
standard research tool (The Picker Patient Experience Questionnaire, PPE-15) in a cohort
study. Results indicated that 86% of these patients were not involved in their care
decisions, and 64% received unclear information, including vague answers to treatment
questions (Lattimer et al., 2010). Likewise, in a cross-sectional study of 95 patients by
Haywood et al. (2010), adult SCD patients made continual subjective reports of negative
experiences when seeking care in health facilities. Clinicians discounted their reported
pain as drug-seeking behavior, leading to a mutual distrust between providers and these
patients. Poor or biased modes of provider communication were associated with negative
patient experiences and lower levels of trust toward providers when seeking treatment for
SCD/VOC in the health setting.
Despite provider attitude biases towards SCD patients, global initiatives for
improving quality of care for these patients may be possible. Knowledge and awareness
are fundamental components of interventions that will improve care and treatment for
these patients. Once this gap has been bridged, providers and healthcare organizations
(hospital EDs, urgent care centers, etc.) may be more apt to institute a tool that supports
treatment for SCD patients.
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A qualitative study by Tanabe et al. (2010) identified an adult treatment tool
(Emergency Department Sickle Cell Assessment of Needs and Strengths or ED-SCANS)
as effective in assisting ED providers to treat patients who have SCD/VOC. This study
assessed variations in clinician perceptions of potential drug-seeking behavior among
patients both in and out of the ED setting, compared to those diagnosed with SCD.
Participants came from seven different states, including Kansas, Tennessee, and
Louisiana, which are neighboring states to Arkansas. A major finding was the rate of
frustration among ED clinicians over numerous ED visits, hospitalizations, and
difficulties maintaining adequate follow-up (outpatient care) and analgesic administration
for these patients.
Pham (2008) found that EDs are the main portals of entry into the health care
system despite their reputation for misdiagnosis, negligence, and medical errors.
Specifically, in 2003 there were more than 1 million ED visits by patients in the United
States (a frequency of two visits per five people). This setting (providing access to care
24 hr daily, 7 days per week) often provides care for persons with minimal or no
insurance, including some patients with SCD who lack optimal outpatient management.
To optimize care, SCD patients must feel that providers are receptive to their
physiological and emotional needs, which will permit a prompt initiation of care
measures (triage, assessment, analgesia, hydration, and discharge planning).
Ratanawongsa et al. (2009) conducted a landmark cohort study that measured the
reliability and validity of an assessment scale that focused on provider attitudes towards
patients with SCD in VOC. This scale (Positive Provider Attitudes toward Sickle Cell, or
PASS, Appendix A), consisting of 10 items, was given to providers within 72 hr of
13

patient treatment. The developers of the PASS questionnaire measured validity and
reliability of the questionnaire using bivariate correlations (p<0.001) with the Medical
Condition Regard Scale (Haywood et al., 2010a).
Furthermore, a study by Haywood et al. (2010b) used a video intervention method
to determine whether provider (N = 276) attitudes towards SCD patients would be
affected. Providers completed the PASS questionnaire before and after watching a video
in which actual patients discussed their negative ED encounters. These encounters
included biased actions by providers in the ED setting that occurred amidst the
tormenting pain caused by VOC. There was a significant difference between pre- and
post-video attitudes towards SCD in a total of three out of four outcome measurement
items, including a profound difference noted in the reduction of negative provider
attitudes towards these patients after viewing the video.
In addition, Odesina (2010) identified pain crises as the main reason that most
patients who suffer from SCD seek treatment in the ED. Her findings validated the
assumption that stigmatization among providers’ leads to deficiencies in prescribed
analgesia for these patients. Odesina (2009) identified the etiology of chronic pain among
SCD patients as follows: organ damage, iron toxicity, neurological damage, and kidney
and liver impairment. These recurrent pain episodes cause deficits in SCD patients’
quality of life (QL). She stated the following:
The combination of constant unpredictable pain, inadequate pain management by
clinicians, and emotional distress is a cycle of despair, which can lead to anxiety
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and depression coupled with the sense of losing control; clinicians must recognize
that improving health outcomes will play a significant role in improving health
related QL (p.8).
Lastly, the Arkansas Legislative Task Force on Sickle Cell Disease (ALTFSCD)
Report to the Arkansas General Assembly (August, 2010) stated the following:
•

SCD affects more than 1,000 Arkansans;

•

poor channels of access for SCD patients increase patient entry into the
hospital setting, especially the ED;

•

great portions of SCD patients are unemployed or work jobs at minimum
wage pay;

•

many Arkansas hospitals are left with unreimbursed charges because of
frequent and repeat ED visits and hospitalizations;

•

there are numerous advantages to the state, the patient, the hospital, and
the community to having improved health outcomes for SCD patients
(Johnson et al., 2010).

To help alleviate the challenges cited, the ALTFSCD outlined eight key
recommendations, which included the development of a Comprehensive Sickle Cell
Program using large centers and peripheral sites in the state of Arkansas. A key
component of this initiative includes the targeting of physicians as a means to educate
and generate change in prior and current practice methodologies in order to institute
change in future practice for patients with SCD.
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The ALTFSCD also states the following:
•

many physicians may not actually know the proper treatment for patients
with SCD due to its low prevalence;

•

pain management is most challenging to physicians because patients
require large doses of opioid analgesia. The recommended protocol is to
deliver a bolus (large dose) of medication to get ahead of the pain curve;

•

providers often misinterpret continued requests for pain medication as
drug-seeking behavior; hence physicians develop perceived biases towards
these patients, thereby demonstrating resistance to prescribing appropriate
doses of medication;

•

patients often feel disrespected by their physicians, developing distrust for
the health care system in general;

•

the care of sickle cell patients is fragmented for adult patients because
there is no comprehensive adult “medical home” for ongoing treatment
and management of SCD;

•

medical providers demonstrate a reluctance to provide local acute care to
these adult patients.

With treatment improvements, morbidity and mortality in the SCD population
would decrease while also resulting in increased cost savings for the health care industry
in Arkansas (Brousseau, 2010). This QI initiative incorporated nursing science and
evidence-based measures to improve provider perceptions and analgesic practices,
thereby enacting change within BHMC-LR. Organizational change must be grounded on
the premise of theory and science to catalyze optimal success of QI initiatives.
16

CHAPTER 4
METHODOLOGY
Design, Setting, Sample
This was a pre-experimental one group pre-test/post-test quality improvement
project to evaluate the effectiveness of implementation of an evidence-based analgesic
algorithm coupled with an intervention on practice change behavior towards patients with
SCD. The intervention was delivered in a private conference room at BHMC-LR ED.
The ED supervisor and medical director scheduled the intervention times and days. The
video was shown on a laptop computer, using an attached speaker for sound clarity. The
analgesic algorithm and the pre-and-post PASS questionnaires were provided in paper
format to all participants.
The participants consisted of ED nurses and physicians employed by (or of
medical staff designation within) BHMC-LR ED for at least 12 months. Exclusion
criteria included employment for fewer than 12 months. There were no racial, ethnic, or
gender exclusions made among the participants. There were no special accommodations
(related to speech, visual, hearing, or physical limitations) required or requested.
Procedure
After receiving approval and proposal acceptance from the University of Nevada
Las Vegas (UNLV) Doctor of Nursing Practice project committee, the BHMC-LR
Corporate Compliance department (with submission of a project approval letter), and the
UNLV Institutional Review Board (IRB), this QI project proceeded.. The DNP student
met with the BHMC-LR ED supervisor and medical director to ascertain that all aspects
of the intervention were reviewed in detail and acceptable to all members of the
17

interdisciplinary team. The ED supervisor scheduled the intervention during participants’
regular work schedule over two weeks in December 2012. Participation in the research
component was voluntary (although the ED supervisor arranged scheduling for all
providers for the intervention).
Intervention
This intervention involved the completion of a pretest questionnaire (for those
who consented to participate in the research portion), viewing an 8-miinute video
(depicting actual patients with SCD and a hematologist describing the impact of SCD and
the obstacles encountered when looking for medical treatment during pain crises), and
presentation of an evidence based analgesic algorithm. The student provided the
participants with the following: purpose for participation (via verbal briefing format),
instructions for participation in the intervention, and privacy and confidentiality
information.
Each participant received a pen and a folder that contained the following:
•

UNLV IRB project approval letter

•

BHMC-LR Corporate Compliance project approval letter

•

informed consent forms

•

unique identifier form (to match pre- and post- questionnaires)

•

procedure instructions

•

color coded questionnaires (yellow=pre, blue=post), and

•

color copies of the ED-SCANS Decision 2 Analgesic Algorithm.

After each participant completed the informed consent and unique identifiers,
they completed the pre-questionnaire, watched the 8-minute video, and then completed
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the post-questionnaire. After that, the student reviewed the ED-SCANS Decision 2
Analgesic algorithm and discussed it with each participant.
Variables
The dependent variables in this study were provider perceptions using a
qualitative Likert scale (pre- and post-intervention) and provider practices of analgesia
prescribing (pre and post intervention) using data obtained from the PCQI report. The
independent variables were watching the 8-minute video and presentation of the
analgesic algorithm (ED-SCANS Decision 2).
Data Collection
Participants completed a questionnaire (PASS) that collected provider perceptual
responses regarding prior interactions with SCD patients, beliefs/opinions about SCD
patients’ pain and potential for manipulation of providers, and overall perceptions
towards SCD patients in general. There were no monetary incentives offered for
participation.
The 10 item PASS questionnaire was developed by Ratanawongsa et al. (2009). It
includes the following items.
Questions 1-3 with Likert scale responses of 1 (much less than average) to 5 (much
more than average):
1. How much do you like this patient (liking means warmth/enthusiasm for seeing)?
2. How much empathy do you have for this patient?
3. How much respect do you have for this patient?
Questions 4-6 with Likert scale responses of 1 (strongly agree) to 5 (strongly
disagree):
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4. This patient was frustrating to take care of;
5. This patient is one of those people who makes me feel glad I went into medicine;
and
6. This patient is the kind of person I could see myself being friends with.
Questions 7-10 with Likert scale responses of 1 (not at all likely) to 5 (extremely
likely):
7. In your opinion, how likely is this patient to over-report (exaggerate) discomfort?
8. In your opinion, how likely is this patient to fail to comply with medical advice?
9. In your opinion, how likely is this patient to abuse drugs, including alcohol? In
your opinion, how likely is this patient to abuse drugs, including alcohol?
10. In your opinion, how likely is this patient to try to manipulate you or other
physicians?
The ED-SCANS Decision 2 Analgesic Algorithm provides dosage recommendations
(per weight in kilograms) using either intravenous or subcutaneous routes of
administration for morphine or hydromorphone in treating SC crisis pain in the ED. The
student gave participants an overview of the algorithm and provided an opportunity to
discuss their thoughts on the intervention and algorithm.
Data Analysis
The participants’ responses and data obtained from the PCQI report were entered
into SPSS Version 19. All user-defined missing values were indicated as missing.
Statistics for each test were based on all cases with valid data for each variable per test.
Paired t-tests were used for data analysis of pre- and post-test PASS scores, and an
independent samples t-test was used for pre-and post-intervention PCQI pain scores.
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The International Classification of Disease (ICD) DRG was used to identify SCD
patient encounters from the PCQI report. A data abstraction tool was used to collect the
data from the PCQI report (25 SCD patient encounters) obtained for the period of 30 days
prior to and 30 days after the intervention. Data were entered into SPSS per subject using
the following variables: triage level of pain (LOP); LOP 1 hour post analgesia
administration; and discharge (from ED) LOP. All user defined missing values were
treated as missing in the data analysis.
The pre- and post-intervention provider response scores were calculated as
follows: the range of scores for the pre and post PASS questionnaires was 1-10 (with 10
being the higher and most positive attitude). The individual pre- scores (for each
questionnaire) were matched with the post- scores using the unique identifiers. A total
score was calculated for each questionnaire; individual questions were not analyzed, in
accordance with the tool’s recommended use.
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CHAPTER 5
RESULTS
PASS questionnaire
Fifty participants completed the pre- and post-questionnaire (Table 1). Using a
paired samples t-test, there was a significant difference at the p<.001 level between the
scores.
Table 1
PASS Questionnaire Results
M

N

SD

SEM

Pre-Intervention

22.20

50

7.809

1.104

Post-Intervention

42.96*

50

5.047

.714

*Significant difference (p<.001)
PCQI
There were some missing data points. In the pre-intervention time period, four
patients had no triage level of pain (LOP) documented. Eight of the patients had no 1 hr
LOP reassessment after receiving analgesia. Seven of the patients had no discharge LOP
documented. In the post-intervention period, four of the patients had no triage LOP
documented. Five patients had no 1 hr LOP documented after anesthesia, and six patients
had no discharge LOP documented.
Using independent samples t-tests, there was no significant difference in Triage
LOP between the pre- and post-intervention samples, indicating the patients’ pain levels
were approximately the same upon admission. However, there was a significant
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difference (p<.002) between Discharge LOP, with the LOP approximately 3 points lower
post-intervention (Table 1).
Table 2
PCQI Results
Pain Measurement
Time

Pre or Post Group

Triage LOP

Pre Intervention

21

7.14

3.425

.747

Post Intervention

21

8.43

2.357

.514

Pre Intervention

17

7.00

1.732

.420

Post Intervention

20

6.10

3.007

.672

Pre Intervention

18

6.67

2.828

.667

Post Intervention

19

3.74

2.535

.582

LOP 1 Hour Post
Analgesia
Discharge LOP*

N

M

SD

SEM

* Significant difference p<.002

Resources and Costs
This project was implemented at no cost to BHMC-LR. The project did not
require any staff overtime or scheduling changes. The student provided all materials
(paper, pens, folders, timer, and laptop) for implementation of the project.
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Project Timeline
The student completed the project proposal defense on July 12, 2012. The initial
proposal defense was on April 26, 2012 but a committee change necessitated a repeat
proposal defense. Permission to proceed with the project was given by BHMC-LR on
August 17, 2012. The student requested a “Letter of Authorization to Conduct Research”
(LACR) from BHMC-LR on August 30, 2013. BHMC-LR did not provide the LACR, a
mandatory requirement by the UNLV IRB, for several months due to bureaucratic
requirements. This delayed the project. On November 12, 2012, BHMC-LR submitted
LACR to the UNLV Office of Research Integrity, which approved the protocol on
November 17, 2012.
The student then began to discuss (with BHMC-LR ED nursing supervisor) dates
for project implementation. There was a delay in scheduling due to the hospital’s
undergoing a transition to electronic medical records September 2012 through December
2012. As a result, the student was not permitted to begin project implementation until
December 2012. Correspondence with the ED Nursing Director, the ED Medical
Director, the ED Nursing Supervisor, and the student determined a beginning
implementation date of December 13, 2012. The PCQI report was reviewed with the ED
supervisor for the 30 days prior to the project intervention. The project was completed on
December 27, 2012. The student and the ED supervisor reviewed the PCQI report one
month after the project was completed, which included all SCD patient encounters during
the 30 days following the intervention. Data analysis was completed January 2013. A
summary of the findings and further recommendations based upon the findings of the
study were made to BHMC-LR stakeholders and the interdisciplinary committee
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February 2013. The final presentation of the DNP Doctoral Project defense was
completed on March 13, 2013. See Appendix E for detailed project timeline.
Ethical Consideration and Human Subjects Protection
The student completed the required CITI course prior to implementation of this
study and maintained compliance with all required ethical principles, protecting the
safety, welfare, and rights of all subjects and participants involved in conducting this
study. Approval was received from the UNLV IRB and BHMC-LR Corporate
Compliance department prior to project implementation. Written consent (containing
research purpose, duration, number of subjects, procedures, exclusions, risks, benefits,
alternatives, new information, confidentiality, and costs, the right to withdraw or refuse,
and contact information) was obtained from all participants. See Appendix F
This project did not require a patient privacy disclosure or direct patient
participation because the PCQI report contained only aggregate data. To maintain privacy
and confidentiality, participants were not required to disclose any personal identifying
information and a unique identifier system was used to compare pre and post
questionnaire results of each participant. Data obtained were used to determine the
effectiveness of the video intervention and the evidence-based analgesic algorithm.
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CHAPTER 6
EVALUATION
This QI project demonstrated positive outcomes from the applied intervention.
The findings of this QI study indicated statistically significant support of the following
outcomes including the following:
•

BHMC-LR ED physicians and nurses demonstrated improved perceptions
towards SCD patients after completing the video intervention; and

•

BHMC-LR ED physicians and nursing clinicians’ post-video practice behavior
demonstrated improvement in providing appropriate SCD treatment to patients as
evidence by a significant improvement in discharge level of pain.

There were some unanticipated findings upon completion of the intervention, which
indicate the need for additional practice change behavior among the nursing clinicians at
BHMC-LR ED. Pain assessment (at triage, one hour after analgesia, and upon discharge)
is imperative for SCD patients. Upon review of the PCQI report (pre-and-post
intervention) it was determined that the nurses were not completing appropriate
assessment of patients LOP at triage, one hour after analgesia, or at discharge. Care could
improve if appropriate nursing assessment of pain is completed as required by The Joint
Commission. In order for providers to institute permanent change in analgesia
prescribing, they must have concise documentation of patients subjective LOP.
Limitations
This QI study had several limitations. The intervention was brief and one time only.
There was no chart review to assess whether prescribing practices had improved or
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whether the changes were sustained over time. The findings did indicate a decrease in
negative provider perceptions towards SCD patients, but there was no repeat testing later
to determine whether or not their perceptions remained improved.
Strengths
This QI project demonstrated that it is possible to change providers’ negative
attitudes towards patients with SCD and to improve their pain management. The
intervention was of low cost; allowing other organizations to replicate this practice
improvement initiative with little disruption to ED provider schedules.
Recommendations
Recommendations to BHMC-LR ED include the following, based upon the
completion of this QI study:
•

quarterly clinical staff educational sessions regarding the importance of
documenting LOP on all patients upon triage, one hour after analgesic
administration, and upon discharge;

•

subjective and objective pain assessment on all patients upon entrance into the
ED, one hour after administration of analgesia, and upon discharge;

•

ED Supervisor to perform monthly PCQI assessment of analgesic practices
among SCD patients who are treated in the ED;

•

monthly clinician (physicians and nurses) meetings to discuss PCQI data and
intervention strategies for improvement in the delivery of health services to SCD
patients;

•

administration monitoring of frequency (increases and decreases) among SCD
patients following this QI project;
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•

ED Supervisor to attend quarterly meetings held by the Arkansas Minority Health
Commission to increase educational awareness about the needs of this patient
population and works currently underway for this population in Arkansas;

•

community alliance between BHMC-LR and the University of Arkansas for
Medical Sciences upcoming Adult Sickle Cell Day Clinic (ASCDC); allowing for
SCD to receive discharge instructions that include follow-up with community
providers and the ASCDC;

•

ED Supervisor to perform quarterly educational opportunities for clinical staff
specific to SCD assessment, treatment, and follow-up; and

•

ED Medical Director to consider adaptation of an analgesic support algorithm in
the ED.
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CHAPTER 7
FISCAL IMPLICATIONS FOR CHANGE
The outcome of this project may result in decreased ED visits, revisits, and
hospitalizations at BHMC-LR. The result is likely to be cost containment by reduction of
SCD patient visits and repeat hospitalizations in the ED.
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CHAPTER 8
SUSTAINING AND MAINTAINING THE CHANGE
Upon completion of this project (intervention, data collection, and data analysis),
the student met with the BHMC-LR interdisciplinary team reviewing the results and
recommendations for practice using the third stage of Lewin’s Change Management
Model. The student reviewed the pre-intervention and post intervention PCQI data in
detail with the team, as well as the results of the pre- and post-intervention provider
responses, based on the video and analgesic algorithm intervention. The ED-SCANS
analgesic algorithm was reviewed with the team and suggested for adoption into practice
in the ED. The benefits of decreased SCD admissions, decreased SCD ED visits, and
increased cost savings for BHMC-LR were all received favorably by the team.
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CHAPTER 9
QUALITY IMPROVEMENT AND DOCTORAL ADVANCED NURSING PRACTICE
This QI project is representative of the standards set forth by the 2006 American
Association of Colleges of Nursing (AACN) Essentials for Doctoral Advanced Nursing
Practice. The following description provides support for this project:
•

Essential I: Outlines that Doctor of Nursing Practice (DNP) graduates possess a
wide array of knowledge from the sciences and have the ability to translate that
knowledge quickly and effectively to benefit patient in the demands of practice
environments;

•

Essential II: States that DNP graduates should be prepared with sophisticated
expertise in assessing organization, identifying systems’ issues, and facilitating
organization-wide changes in practice delivery. In addition, Advanced Nursing
Practice requires political skills, systems thinking, and the business and financial
acumen needed for the analysis of practice quality and costs;

•

Essential III: States that the scholar applies knowledge to solve a problem via the
scholarship of application (referred to as the scholarship of practice in nursing).
This application involves the translation of research in to practice and the
dissemination and integration of new knowledge, which are key activities of DNP
graduates. The scholarship of application expands the realm of knowledge beyond
mere discovery and directs it toward humane ends. Nursing practice epitomizes
the scholarship of application through its position where the sciences, human
caring, and human needs meet and new understanding emerge;
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•

The goal of Evidence-Based practice as per the student’s anticipated role as a
DNP is that of promoting effective nursing interventions, efficient care, and
improved outcomes for patients and to provide the best available evidence for
clinical, administrative, and educational decision making. DNP graduates have a
significant role in advancing the production of nursing knowledge. It is essential
to link the synergy for knowledge with the practice and dissemination of
knowledge and theoretical thinking. This QI project is a clear demonstration of
the integration of the essentials set forth by the AACN and the student’s ability to
represent these channels of doctoral advanced nursing practice.
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CHAPTER 10
IMPLICATIONS FOR PRACTICE AND CONCLUSION
SCD is an incurable chronic disease, and the delivery of health services to SCD
patients must integrate measures for the bridging of current gaps in legislation and
clinical treatment. QI initiatives must be predicated on evidence-based measures by
which care for these patients can be optimized. It is essential that providers have a
formidable knowledge base regarding the treatment of SCD and VOC, including the
imperative nature of prompt recognition and treatment in the ED setting.
According to Smith, Oyeku, Homer, and Zuckerman (2006), there is a nationwide
focus on QI for the delivery of medical care. However, there has been minimal actual
progression in the channels of care for SCD or in the development of new models
(including refinement of older models of care) of QI for SCD, which continue to impede
the delivery of health services for SCD treatment. DNP clinicians have the knowledge
and clinical expertise to develop interventions for QI among SCD patients, including
reformation of current models of care delivery. DNPs are essential agents of
dissemination for improved methods of access, improved cost-efficacy, reduction of
provider frustration via the promotion of community resources for outpatient
management of SCD, and in improving outcomes in treatment for patients who suffer
from SCD.
Conclusion
This project improved outcomes for SCD patients and will likely reduce ED and
hospital readmission rates at BHMC-LR. The administrators, ED Medical Director, ED
Nursing Director, and ED Nursing Supervisor are considering the adoption of a decision
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support tool (i.e., ED-SCANS) to help support future decision-making and treatment of
SCD patients in the ED.
The Doctor of Nursing Practice (DNP) team leader mobilized BHMC-LR
stakeholders to unite in achieving the common goal of improving outcomes, increasing
containment, and improving life quality and health outcomes for SCD patients at BHMCLR. Levasseur (2001) found that if a crisis motivates a change, and if this change is
motivated by a need to improve a given system’s productivity, then actual change is
possible. Using this model demonstrated improvement in the perceptions and attitudes of
BHMC-LR ED providers and provoked measures for sustaining this level of treatment at
this ED. By problem identification, solution development, change implementation, and
the re-establishment of balance in practice behavior (Buonocore, 2004), BHMC-LR
demonstrated an evidence-based change in practice behaviors, optimizing and enhancing
treatment for SCD patients in the ED.
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APPENDIX A: PASS QUESTIONNAIRE
Positive Provider Attitudes toward Sickle Cell Patients Scale (PASS) Score
Source: Ratanawongsa N, Haywood C, Bediako SM, Lattimer L, Lanzkron S, Hill PM, Neil R. Powe NR,
Beach MC. “Health care provider attitudes towards patients with acute vaso-occlusive crisis due to sickle
cell disease: development of a scale.” Patient Education and Counseling 2009. 76(2):272-8.
Not every patient is regarded the same.
Compared to the average patient……
1. How much do you like this patient? (Liking
means warmth/enthusiasm for seeing)
2. How much empathy do you have for this
patient?
3. How much respect do you have for this
patient?

Much less
than average

Less than
average

Average

More than
average

Much more
than average

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

4. This patient was frustrating to take care of.

1

2

3

4

5

5. This patient is one of those people who make me
feel glad I went into medicine.

1

2

3

4

5

6. This patient is the kind of person I could see
myself being friends with.

1

2

3

4

5

Not at all
likely

A little
likely

Somewhat
likely

Very likely

Extremely
likely

7. …over-report (exaggerate) discomfort?

1

2

3

4

5

8. …fail to comply with medical advice?

1

2

3

4

5

9. …abuse drugs, including alcohol?

1

2

3

4

5

10.…. try to manipulate you or other physicians?

1

2

3

4

5

Severe pain

Moderate
pain

Mild pain

Minimal
pain

No pain

2

3

4

5

In your opinion, how likely is this patient to…..

Additional item (not part of PASS score):
Compared to other patients with pain crises, how
severe do you think the pain was in this patient?

1
•
•
•
•

Total possible score: 10 – 50 (higher scores indicate more positive attitudes)
Items 5-10 are reverse-scored.
Cronbach’s alpha in study = 0.913
Item sources:
•
Newly-created items: questions 3, 5, and 7
•
Question 1: Hall JA, Horgan TG, Stein TS, Roter DL. Liking in the physician--patient relationship. Patient Educ
Couns 2002; 48(1):69-77.
•
Question 3: Beach MC, Roter DL, Cooper LA. Are physicians’ attitudes of respect accurately perceived by patients
and associated with more positive communication behaviors? Patient Educ Couns 2006; 51: 347-54.
•
Questions 7-10: van Ryn M, Burke J. The effect of patient race and socioeconomic status on physicians’ perceptions
of patients. Soc Sci Med 2000; 50: 813-28.
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APPENDIX B: CRISIS VIDEO LINK
“CRISIS: Experiences of People with Sickle Cell Disease Seeking Healthcare for Pain”
Copy the following hyperlink into an Internet browser:
http://www.sicklecellrespect.org
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APPENDIX C: ED-SCANS DECISION 2 ALGORITHM
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APPENDIX D: DETAILED PROJECT TIMELINE
Project Task
• Initial Project Proposal Defense to Project Committee
• Project Committee Member Change Completed
• Completion of Recommended Changes to Project Proposal
• Proposal turned in to Project Chair
• Proposal Defense to Project Committee
• Authorization to Proceed with Project Received from BHMC-LR
Corporate Compliance Department
• Initial Letter of Authorization to Conduct Research received from BHMCLR
• Meeting held between Project Chair, BHMC-LR QI Director, and student
• Revised and completed Letter of Authorization to Conduct Research
received from BHMC-LR Corporate Compliance Department
• UNLV IRB protocol approval received/Expedited Review
• Student and BHMC-LR ED Supervisor planning for project
implementation dates
• Project implementation began at BHMC-LR ED
• Review of PCQI Report (30 days prior to period before intervention)
• Conclusion of project implementation at BHMC-LR ED
• Review of PCQI Report (30 day time period following intervention)
• Data Analysis with Project Chair
•
•
•

Summary and presentation of findings to BHMC-LR stakeholders
Completion of Writing of Final Project
Final Project Oral Defense

38

Dates
April 26, 2012
May 7, 2012
June 26, 2012
June 29, 2012
July 12, 2012
August 17, 2012
August 27, 2012
November 12, 2012
November 12, 2012
November 17, 2012
November 18, 2012
December 13, 2012
December 27, 2012
January 23, 2013
January/February
2013
February 2013
February 2013
March 13, 2013

APPENDIX E: UNLV APPROVED INFORMED CONSENT

INFORMED CONSENT
Department of Nursing
TITLE OF STUDY:
Sickle Cell Disease: A Quality Improvement Initiative for Emergency Department Providers
INVESTIGATOR(S): Nancy Menzel, PhD, RN; Pretrescia Walker, MNSc. APN, ACNP
For questions or concerns about the study, you may contact Pretrescia Walker at (501)-766-3648
or Nancy Menzel at (702) 895-5970.
For questions regarding the rights of research subjects, any complaints or comments regarding
the manner in which the study is being conducted, contact the UNLV Office of Research
Integrity – Human Subjects at 702-895-2794, toll free at 877-895-2794 or via email at
IRB@unlv.edu.
Purpose of the Study
You are invited to participate in a research study. The purpose of this study is to improve current
analgesic practices for Sickle Cell Disease patients at Baptist Health Medical Center-Little Rock,
Arkansas.
Participants
You are being asked to participate in the study because you fit this criteria: You are either a
nurse or physician, employed (for greater than 12 months) by or with staff designation at Baptist
Health Medical Center-Little Rock, Arkansas.
Procedures
If you volunteer to participate in this study, you will be asked to do the following: You will be
asked to complete the pre-training questionnaire “Positive Provider Attitudes Towards Sickle
Cell Patients Scale” (PASS), then watch the 7-minute video “Crisis: Experienced of People With
Sickle Cell Disease Seeking Healthcare for Pain,” then complete the post-training PASS
questionnaire, then attend a 10-minute presentation on an analgesic support algorithm entitled
Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS).

39

Benefits of Participation
You may benefit from participating in this study by having an increased awareness of the
analgesic needs of patients who present to the Emergency Department for treatment.
Risks of Participation
There are risks involved in all research studies. This study may include only minimal risks. You
may become uncomfortable when watching the video or in answering some of the questions on
the questionnaire.
Cost /Compensation
There are no financial costs to you to participate in this study. The study will take 30 minutes of
your time during your scheduled shift. There will be no compensation for your time.
Confidentiality
All information gathered in this study will be kept as confidential as possible. No reference will
be made in written or oral materials that could link you to this study. All records will be stored
in a locked facility at UNLV for 3 years after completion of the study. After the storage time,
the information gathered will be shredded.
Voluntary Participation
Your participation in this study is voluntary. You may refuse to participate in this study or in any
part of this study. You may withdraw at any time without prejudice to your relations with
UNLV or Baptist Health Medical Center. You are encouraged to ask questions about this study
at the beginning or any time during the research study.
Participant Consent:
I have read the above information and agree to participate in this study. I have been able to ask
questions about the research study. I am at least 18 years of age. A copy of this form has been
given to me.

Signature of Participant

Date

Participant Name (Please Print)
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APPENDIX F: UNLV IRB PROTOCOL APPROVAL EXPEDITED REVIEW

Biomedical IRB – Expedited Review
Approval Notice
NOTICE TO ALL RESEARCHERS:
Please be aware that a protocol violation (e.g., failure to submit a modification for any change) of an IRB approved
protocol may result in mandatory remedial education, additional audits, re-consenting subjects, researcher
probation, suspension of any research protocol at issue, suspension of additional existing research protocols,
invalidation of all research conducted under the research protocol at issue, and further appropriate consequences
as determined by the IRB and the Institutional Officer.
DATE:

November 14, 2012

TO:

Dr. Nancy Menzel, Nursing

FROM:

Office of Research Integrity - Human Subjects

RE:

Notification of IRB Action
Protocol Title: Sickle Cell Disease: A Quality Improvement Initiative for Emergency
Department Providers
Protocol #: 1209-4242
Expiration Date: November 13, 2013

____________________________________________________________________________________
This memorandum is notification that the project referenced above has been reviewed and approved by the UNLV Biomedical
Institutional Review Board (IRB) as indicated in Federal regulatory statutes 45 CFR 46 and UNLV Human Research Policies and
Procedures.
The protocol is approved for a period of one year and expires November 13, 2013. If the above-referenced project has not been
completed by this date you must request renewal by submitting a Continuing Review Request form 30 days before the expiration
date.
PLEASE NOTE:
Upon approval, the research team is responsible for conducting the research as stated in the protocol most recently reviewed and
approved by the IRB, which shall include using the most recently submitted Informed Consent/Assent forms and recruitment
materials. The official versions of these forms are indicated by footer which contains approval and expiration dates.
Should there be any change to the protocol, it will be necessary to submit a Modification Form through ORI - Human Subjects.
No changes may be made to the existing protocol until modifications have been approved by the IRB. Modified versions of
protocol materials must be used upon review and approval. Unanticipated problems, deviations to protocols, and adverse events
must be reported to the ORI – HS within 10 days of occurrence.

If you have questions or require any assistance, please contact the Office of Research Integrity - Human Subjects at
IRB@unlv.edu or call 895-2794.
Office of Research Integrity - Human Subjects 4505 Maryland Parkway • Box 451047 • Las Vegas, Nevada 89154-1047
(702) 895-2794 • FAX: (702) 895-0805
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APPENDIX G: BHMC-LR LETTER OF AUTHORIZATION
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APPENDIX H: DATA ABSTRACTION TOOL

Subject
#

Triage LOP
Score
(1-10)

1 Hour After Analgesia LOP Score
(1-10)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
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Discharge LOP
Score
(1-10)
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